Active substances
Hyaluronate + Trehalose
- SFDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| BIOSOFT PLUS EYE DROP | 2,0.25 %,% | Eye drops · Ophthalmic use | 1 Bottle | SAR 31.10 | Generic · OTC | Oy Finnsusp Ab | Valid |
| BioSoft Plus SD Eye Drops | 2 , 0.25 % | Eye drops · Ophthalmic use | 30 Vial | SAR 46.10 | Generic · OTC | Oy Finnsusp Ab | Withdrawn by MAH · Not Marketed |
| THEALOZ DUO EYE DROP | 0.15,3 %,% | Eye drops · Ophthalmic use | 1 Bottle | SAR 28.35 | Generic · OTC | LABORATORIES THEA S.I.S | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ALLERGIC RHINITIS-ALLERGIC RHINO-CONJUNCTIVITIS; ANESTHESIA-SUPPORTIVE AGENTS/ EYE DRYNESS IN PATIENTS RECEIVING CONTINUOUS INFUSIONS OF NEUROMUSCULAR BLOCKERS.; VIRAL CONJUNCTIVITS, HERPESVIRAL KERATITIS, HERPESVIRAL CONJUNCTIVITIS, VARICELLA KERATITIS, ZOSTER CONJUNCTIVITIS, ZOSTER KERATITIS, MEASLES KERATITIS AND KERATOCONJUNCTIVITIS, VIRAL CONJUNCTIVITIS, KERATITIS
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.